Literature DB >> 30770555

Berberine as a potential autophagy modulator.

Reza Mohammadinejad1, Zahra Ahmadi2, Shima Tavakol3, Milad Ashrafizadeh4.   

Abstract

Today, pharmacognosy is considered a valuable science in the prevention and treatment of diseases. Among herbals, Berberine is an isoquinoline alkaloid found in the Berberis species. Surprisingly, it shows antimicrobial, antiviral, antidiarrheal, antipyretic, and anti-inflammatory potential. Furthermore, it diminishes drug resistance in cancer therapy and enhances tumor suppression in part through autophagy and cell cycle arrest mechanisms. In the present review, we discuss the effect of berberine on diverse cellular pathways and describe how berberine acts as an autophagy modulator to adjust physiologic and pathologic conditions and diminishes drug resistance in cancer therapy.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  autophagy; berberine; drug-resistant; pharmacognosy; programmed cell death

Year:  2019        PMID: 30770555     DOI: 10.1002/jcp.28325

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  21 in total

Review 1.  Flaming the fight against cancer cells: the role of microRNA-93.

Authors:  Milad Ashrafizadeh; Masoud Najafi; Reza Mohammadinejad; Tahereh Farkhondeh; Saeed Samarghandian
Journal:  Cancer Cell Int       Date:  2020-06-29       Impact factor: 5.722

2.  Berberine Attenuates Arterial Plaque Formation in Atherosclerotic Rats with Damp-Heat Syndrome via Regulating Autophagy.

Authors:  Xiao Ke; Yiteng Huang; Liang Li; Fuya Xin; Luhua Xu; Yuangui Zhang; Zhicong Zeng; Fengxia Lin; Yinzhi Song
Journal:  Drug Des Devel Ther       Date:  2020-06-23       Impact factor: 4.162

Review 3.  Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems.

Authors:  Shima Tavakol; Milad Ashrafizadeh; Shuo Deng; Maryam Azarian; Asghar Abdoli; Mahsa Motavaf; Delaram Poormoghadam; Hashem Khanbabaei; Elham Ghasemipour Afshar; Ali Mandegary; Abbas Pardakhty; Celestial T Yap; Reza Mohammadinejad; Alan Prem Kumar
Journal:  Biomolecules       Date:  2019-09-25

4.  Innovative approaches for cancer treatment: current perspectives and new challenges.

Authors:  Carlotta Pucci; Chiara Martinelli; Gianni Ciofani
Journal:  Ecancermedicalscience       Date:  2019

Review 5.  Lysosomes as a therapeutic target.

Authors:  Srinivasa Reddy Bonam; Fengjuan Wang; Sylviane Muller
Journal:  Nat Rev Drug Discov       Date:  2019-09-02       Impact factor: 84.694

Review 6.  Nanoparticles Targeting STATs in Cancer Therapy.

Authors:  Milad Ashrafizadeh; Zahra Ahmadi; Niranjan G Kotla; Elham Ghasemipour Afshar; Saeed Samarghandian; Ali Mandegary; Abbas Pardakhty; Reza Mohammadinejad; Gautam Sethi
Journal:  Cells       Date:  2019-09-27       Impact factor: 6.600

Review 7.  Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways.

Authors:  Milad Ashrafizadeh; Hossein Rafiei; Reza Mohammadinejad; Tahereh Farkhondeh; Saeed Samarghandian
Journal:  Cancer Cell Int       Date:  2021-01-21       Impact factor: 5.722

8.  Gandouling Tablets Inhibit Excessive Mitophagy in Toxic Milk (TX) Model Mouse of Wilson Disease via Pink1/Parkin Pathway.

Authors:  Jing Zhang; Lu-Lu Tang; Liang-Yong Li; Shen-Wei Cui; Shan Jin; Huai-Zhen Chen; Wen-Ming Yang; Dao-Jun Xie; Gu-Ran Yu
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-14       Impact factor: 2.629

Review 9.  Curcumin Delivery Mediated by Bio-Based Nanoparticles: A Review.

Authors:  Mahshid Moballegh Nasery; Banafshe Abadi; Delaram Poormoghadam; Ali Zarrabi; Peyman Keyhanvar; Hashem Khanbabaei; Milad Ashrafizadeh; Reza Mohammadinejad; Shima Tavakol; Gautam Sethi
Journal:  Molecules       Date:  2020-02-06       Impact factor: 4.411

10.  Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells.

Authors:  Ge Li; Chuang Zhang; Wei Liang; Yanbing Zhang; Yunheng Shen; Xinhui Tian
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.